Related Experiment Video
Updated: Feb 3, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Traditional Chinese Medicine Syndrome Patterns and Their Association with Hepatitis B Surface Antigen Levels during
He-Ping Xie1,2,3, Zhi-Ping Liu4, Jiong-Shan Zhang1,2
1Department of Integrative Chinese and Western Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China.
Insights
Traditional Chinese Medicine Syndrome (TCMS) patterns change during chronic hepatitis B virus (CHB) infection. Specific TCMS patterns correlate with hepatitis B surface antigen (HBsAg) levels, offering insights into CHB progression and treatment.
Area of Science:
- Integrative Medicine
- Hepatology
- Traditional Chinese Medicine (TCM)
Background:
- Chronic hepatitis B virus (CHB) infection is a global health concern with a complex natural history.
- Traditional Chinese Medicine Syndrome (TCMS) patterns are used to categorize patient presentations in TCM.
- Understanding the relationship between TCMS patterns and viral markers like hepatitis B surface antigen (HBsAg) is crucial for comprehensive patient management.
Purpose of the Study:
- To investigate the association between TCMS patterns and HBsAg levels throughout the natural history of CHB.
- To analyze how TCMS patterns evolve across different phases of CHB, including immune tolerance, clearance, low replication, reactivation, cirrhosis, and primary liver cancer.
Main Methods:
- Categorization of 289 CHB patients into distinct phases of the disease natural history.
- Classification of patients into five primary TCMS patterns: spleen-kidney deficiency (SKD), liver-qi depression (LQD), damp-heat in liver-gallbladder (LGDH), liver-kidney deficiency (LKD), and blood stasis blocking collateral (BSBC).
- Statistical analysis of HBsAg levels and other serological indicators in relation to TCMS patterns and CHB phases.
Main Results:
- TCMS patterns showed statistically significant differences across the various CHB phases (P < 0.001).
- Predominant patterns varied by disease stage: SKD in the inactive stage, LGDH in the active stage, and BSBC in the advanced stage.
- Median HBsAg levels differed significantly among TCMS patterns (P < 0.001), with the highest levels in SKD and lowest in LKD and BSBC.
Conclusions:
- TCMS patterns are dynamic and change during the natural history of CHB.
- A significant correlation exists between specific TCMS patterns and HBsAg titers.
- These findings may inform TCM-based therapeutic strategies for managing CHB.
Abstract:
The aim of this study is to investigate traditional Chinese medicine syndrome (TCMS) patterns and their association with hepatitis B surface antigen (HBsAg) levels during the natural history of chronic hepatitis B virus infection (CHB). Patients were categorized according to the phase of CHB, as follows: immune tolerance (ITP); immune clearance (ICP); low or nonreplication (LRP); reactivation (RAP); hepatic cirrhosis (HC); and primary liver cancer (PLC). TCMS patterns were classified among the following types: spleen-kidney deficiency (SKD); liver-qi depression (LQD); damp-heat in liver-gallbladder (LGDH); liver-kidney deficiency (LKD); and blood stasis blocking collateral (BSBC). HBsAg levels and other serological indicators were quantified for all patients and their association with TCMS was statistically analyzed and determined. Two hundred and eighty-nine patients with CHB were included. During the natural history of CHB, TCMS patterns were statistically different among the different phases (P < 0.001). The most frequently occurring syndromes among the six progressive phases were SKD, LGDH, LKD, LGDH, BSBC, and LGDH, respectively. The predominant patterns in the inactive stage (ITP + LRP), active stage (ICP + RAP), and late or advanced stage (HC + PLC) were SKD (31%), LGDH (51.8%) and BSBC (34.4%), respectively. Median HBsAg levels were also statistically different among the five patterns of TCMS (P < 0.001). The highest HBsAg levels were observed in SKD (4.48 log10 IU/mL). Medium levels were in LQD (3.91 log10 IU/mL) and LGDH (3.90 log10 IU/mL). The lowest HBsAg levels were in LKD (3.60 log10 IU/mL) and the second lowest levels in BSBC (3.81 log10 IU/mL). In addition, HBsAg levels in LKD and BSBC were significantly lower than those in SKD, LQD, and LGDH (P < 0.05 or 0.001). TCMS was altered during the natural history of CHB and correlated with HBsAg titers. This study could provide further insight into the therapy of CHB.
More Related Videos
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters